CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: inosine
Accession: CHEBI:17596
browse the term
Definition: A purine nucleoside in which hypoxanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond.
Synonyms: exact_synonym: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-3,4-diol
related_synonym: 9-beta-D-ribofuranosyl-9H-purin-6-ol; 9-beta-D-ribofuranosylhypoxanthine; Formula=C10H12N4O5; InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1; InChIKey=UGQMRVRMYYASKQ-KQYNXXCUSA-N; Inosin; SMILES=OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(O)ncnc12; hypoxanthine D-riboside; hypoxanthosine; i; inosina; inosinum
alt_id: CHEBI:14456; CHEBI:24841; CHEBI:44407; CHEBI:5927
xref: CAS:58-63-9; Drug_Central:3301; ECMDB:ECMDB00195; Gmelin:489332; HMDB:HMDB0000195; KEGG:C00294; KEGG:D00054; KNApSAcK:C00019692
xref_mesh: MESH:D007288
xref: MetaCyc:INOSINE; PDBeChem:NOS; PMID:22770225; Reaxys:624889; Wikipedia:Inosine; YMDB:YMDB00510
G
Ada
adenosine deaminase
decreases abundance increases abundance
ISO
ADA alternative form results in decreased abundance of Inosine ADA protein results in increased abundance of Inosine
CTD
PMID:16221767
NCBI chr 3:152,398,745...152,422,854
Ensembl chr 3:152,398,747...152,447,088
G
App
amyloid beta precursor protein
multiple interactions
ISO
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine]
CTD
PMID:39172838
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Faslg
Fas ligand
increases expression
ISO
Inosine results in increased expression of FASLG protein
CTD
PMID:16419169
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
H2ax
H2A.X variant histone
multiple interactions
ISO
Inosine inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of H2AX protein modified form]
CTD
PMID:32941855
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Psen1
presenilin 1
multiple interactions
ISO
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of Inosine]
CTD
PMID:39172838
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
G
Slc29a1
solute carrier family 29 member 1
multiple interactions
ISO EXP
Inosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]
CTD
PMID:9353301 PMID:11085929
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
G
Slc29a2
solute carrier family 29 member 2
multiple interactions
ISO
Inosine inhibits the reaction [SLC29A2 protein results in increased uptake of Uridine]
CTD
PMID:11085929
NCBI chr 1:202,327,641...202,335,185
Ensembl chr 1:202,327,354...202,335,171
G
Tp53bp1
tumor protein p53 binding protein 1
multiple interactions
ISO
Inosine inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]
CTD
PMID:32941855
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19899
role
19869
biological role
19867
biochemical role
19574
metabolite
19561
fundamental metabolite
14543
hypoxanthine
38
inosine
8
1-methylinosine
0
2'-O-methylinosine
0
2'-deoxyinosine
0
3',5'-cyclic IMP
0
5'-S-methyl-5'-thioinosine
0
5'-deoxyinosine
0
6-O-methylinosine
0
6-deoxyinosine 5'-phosphate
0
7-methylinosine
0
Phosphoric acid mono-[(2R,3S,4R,5R)-5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester
0
Path 2
CHEBI ontology
19899
subatomic particle
19897
composite particle
19897
hadron
19897
baryon
19897
nucleon
19897
atomic nucleus
19897
atom
19897
main group element atom
19835
p-block element atom
19835
carbon group element atom
19776
carbon atom
19772
organic molecular entity
19772
heteroorganic entity
19532
organochalcogen compound
19293
organooxygen compound
19209
carbohydrates and carbohydrate derivatives
15308
carbohydrate
15308
carbohydrate derivative
14322
glycosyl compound
13083
N-glycosyl compound
5882
nucleoside
5740
ribonucleoside
1165
purine ribonucleoside
822
purines D-ribonucleoside
420
inosine
8
1-methylinosine
0
2'-O-methylinosine
0
2'-deoxyinosine
0
3',5'-cyclic IMP
0
5'-S-methyl-5'-thioinosine
0
5'-deoxyinosine
0
6-O-methylinosine
0
6-deoxyinosine 5'-phosphate
0
7-methylinosine
0
Phosphoric acid mono-[(2R,3S,4R,5R)-5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester
0